Search for page Ko te ohorere
Displaying 161 - 170 of 443 results for "more accurate or more accurately"
-
Highlights in 2024/25
Some of the work highlighted in our Annual report
-
User guide to the Atlas in Healthcare Variation
The Atlas is a powerful tool which allows us to look at heath care variation in New Zealand. The Atlas is quite simple to use but we recommend you read the following guidance on creating reports first to ensure you get the best out of it.
-
Polypharmacy in people aged 65 and over
The goal of this Atlas domain is to identify whether there is significant variation in the dispensing rates of long-term medications among people aged 65 and over, that may highlight areas that warrant further local investigation.
- Polypharmacy and deprescribing (Frailty care guides 2023)
-
Raising the bar on the national patient experience survey: phase one
Raising the Bar on the National Patient Experience Survey responds to the adult national inpatient experience survey results by investigating the lower scoring areas of the survey and recommending interventions to improve these results.
-
Adverse events exception reporting 2020/21: Thematic analysis involving Māori and Pacific peoples
This paper presents a thematic analysis of severity assessment code (SAC)-1 and 2 adverse events involving Māori and Pacific peoples reported to Te Tāhū Hauora Health Quality & Safety Commission from 1 July 2017 to 30 June 2021.
- Community use of antibiotics
-
Opioids
The opioids domain of the Atlas of Healthcare Variation gives an overview on the dispensing of opioids by demographics and health district to identify areas of wide variation.
-
New report highlights deaths of mothers and babies due to family violence
Investigating early interventions to save the lives of mothers and babies is one of the actions set to follow a report examining violence-related deaths of women and girls in Aotearoa New Zealand.
-
Chronic Obstructive Pulmonary Disease in people aged 45 and over
The goal of this Atlas domain is to highlight variation in the prevalence, admissions, and medicine use of people estimated to have Chronic Obstructive Pulmonary Disease (COPD).